The re-rate journey, page-292

I like the join the dots thinking.

In my view and this happens with many stocks, once they have their CR done it's simply down to business, which makes shareholders feel like there is little communication. Meanwhile many things are happening in the background, and I'm sure once a decent milestone is hit then we will have an announcement.

Just think how tight lipped the company was about the FDA approval, where the stock was 1c the previous day, then 2 days later 17.5c. This shows a professional approach.

The main news I was to see is the CLIA waiver for FebriDx, with this it will mean game on. Anything else like ViraDx sales are just a bonus.